Article
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes
8 Jan 2019
Abstract excerpt
BACKGROUND: Ampullary carcinoma (AC) is a rare gastrointestinal cancer. Pathogenic germline alterations (PGAs) in BRCA2 and potentially targetable somatic alterations (SAs) in ERBB2 and ELF3 have been previously described in AC. Memorial Sloan Kettering Cancer Center has implemented an opt-in strategy for germline testing (GT) and somatic testing (ST) for patients with AC to further evaluate the spectrum of PGAs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
